Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility

被引:95
|
作者
Miki, T
Minami, K
Shinozaki, H
Matsumura, K
Saraya, A
Ikeda, H
Yamada, Y
Holst, JJ
Seino, S
机构
[1] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan
[2] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 606, Japan
[3] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan
[5] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark
关键词
D O I
10.2337/diabetes.54.4.1056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucose-induced insulin secretion from pancreatic! P-cells depends critically on ATP-sensitive K+ channel (K-ATP channel) activity, but it is not known whether KATP channels are involved in the potentiation of insulin secretion by glucose-dependent insulinotropic polypeptide (GIP). In mice lacking K-ATP channels (Kir6.2(-/-) mice), we found that pretreatment with GIP in vivo failed to blunt the rise in blood glucose levels after oral glucose load. In Kir6.2(-/-) mice, potentiation of insulin secretion by GIP in vivo was markedly attenuated, indicating that KATP channels are essential in the insulinotropic effect of GIP. In contrast, pretreatment with glucagon-like peptide-1 (GLP-1) in Kir6.2(-/-) mice potentiated insulin secretion and blunted the rise in blood glucose levels. We also found that GLP-1 inhibited gut motility whereas GIP did not. Perfusion experiments of Kir6.2(-/-) mice revealed severely impaired potentiation of insulin secretion by 1 nmol/l GIP and substantial potentiation by 1 nmol/l GLP-1. Although both GIP and GLP-1 increase the intracellular cAMP concentration and potentiate insulin secretion, these results demonstrate that the GLP-1 and GIP signaling pathways involve the KATP channel differently.
引用
收藏
页码:1056 / 1063
页数:8
相关论文
共 50 条
  • [1] Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion
    Reimann, Frank
    Gribble, Fiona M.
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 : 13 - 19
  • [2] Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
    Seino, Yusuke
    Maekawa, Ryuya
    Ogata, Hidetada
    Hayashi, Yoshitaka
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 : 27 - 32
  • [3] Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: Characteristics and regulation
    Alsalim, Wathik
    Lindgren, Ola
    Ahren, Bo
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 354 - 361
  • [4] Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on β-cell secretion and insulin clearance in mice
    Pacini, Giovanni
    Thomaseth, Karl
    Ahren, Bo
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (07): : 988 - 992
  • [5] Nutrient-induced secretion and metabolic effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
    Knapper, JME
    Morgan, LM
    Fletcher, JM
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1996, 55 (1B) : 291 - 305
  • [6] Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists
    Tuzun, Dilek
    [J]. TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 26 (02) : 92 - 96
  • [7] Glucose-dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 Modulate β-Cell Chromatin Structure
    Kim, Su-Jin
    Nian, Cuilan
    McIntosh, Christopher H. S.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (19) : 12896 - 12904
  • [8] Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas
    Seino, Yutaka
    Yabe, Daisuke
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02) : 108 - 130
  • [9] Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose
    Roge, Rikke M.
    Bagger, Jonatan I.
    Alskar, Oskar
    Kristensen, Niels R.
    Klim, Soren
    Holst, Jens J.
    Ingwersen, Steen H.
    Karlsson, Mats O.
    Knop, Filip K.
    Vilsboll, Tina
    Kjellsson, Maria C.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (04) : 290 - 297
  • [10] Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
    Ranganath, L. R.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (04) : 401 - 409